Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Addict Biol. 2015 May 14;21(4):895–903. doi: 10.1111/adb.12261

Figure 1.

Figure 1

Maximum cumulative SOWS scores (mean ± 95% confidence limits) for each study week (Week 1, morphine stabilization; Week 2, initiation of Ibudilast administration; Week 3, morphine discontinuation) according to treatment group (Active Group, N = 20; Placebo Group N = 10).